This study will be a multicentre prospective randomized trial to assess the percentage of
patients with IBD who, after stopping anti-TNF treatment, have sustained clinical remission
at one year compared to those in which the treatment is continued at stable doses
Phase:
Phase 4
Details
Lead Sponsor:
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa